
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
DIVI | NSE | INR | Real-time | |
DIVIc1:NS | NSE | INR | Delayed | |
DIVIc2:NS | NSE | INR | Delayed | |
DIVI | BSE | INR | Delayed |
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as lutein and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.
Name | Age | Since | Title |
---|---|---|---|
Rameshbabu Venkata Nimmagadda | - | 2017 | Independent Non-Executive Chairman |
Sunaina Singh | 68 | 2019 | Non-Executive Independent Director |
Kosaraju Veerayya Chowdary | 70 | 2020 | Non-Executive Independent Director |
Seru Ganapaty | 71 | 2017 | Non-Executive Independent Director |
Kiran Satchandra Divi | 48 | 2001 | CEO & Whole-Time Director |
Venkata Ramana Nimmagadda | 66 | - | Executive Director |
Murali Krishna Prasad Divi | 73 | 1990 | MD & Executive Director |
Devendra Rao Sureddy | 63 | 2024 | Whole-Time Director (Manufacturing) |
Nilima Prasad Divi | 42 | 2017 | Whole-time Director, Chief Control Officer & Director of Commercial |
Rajendra Kumar Premchand | 64 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review